Protein C activation in NIDDM patients

[1]  C. Esmon,et al.  Protein C Inhibitor Is a Potent Inhibitor of the Thrombin-Thrombomodulin Complex (*) , 1995, The Journal of Biological Chemistry.

[2]  G. Schernthaner,et al.  Enhanced Anticoagulant Response to Activated Protein C in Patients With IDDM , 1995, Diabetes.

[3]  J. Amiral,et al.  New direct assay of free protein S antigen using two distinct monoclonal antibodies specific for the free form , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[4]  S. Béguin,et al.  A New Assay Based on Thrombin Generation Inhibition to Detect Both Protein C and Protein S Deficiencies in Plasma , 1994, Thrombosis and Haemostasis.

[5]  E. Falleti,et al.  Fibrinogen Plasma Levels as a Marker of Thrombin Activation in Diabetes , 1994, Diabetes.

[6]  G. Pagano,et al.  PAI-1 and Factor VII Activity Are Higher in IDDM Patients With Microalbuminuria , 1994, Diabetes.

[7]  J. Nishioka,et al.  Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism. , 1994, Thrombosis and haemostasis.

[8]  A. Pileri,et al.  Microalbuminuria in insulin-dependent diabetes is associated with high levels of prothrombin fragment 1 + 2. , 1993, Thrombosis Research.

[9]  G. Hunder,et al.  Serum ELAM-1 is increased in vasculitis, scleroderma, and systemic lupus erythematosus. , 1993, The Journal of rheumatology.

[10]  A. Jenkins,et al.  Prothrombotic and Antithrombotic Factors are Elevated in Patients with Type 1 Diabetes Complicated by Microalbuminuria , 1993, Diabetic medicine : a journal of the British Diabetic Association.

[11]  W. Naser,et al.  A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation in vivo. , 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[12]  U. Lindahl,et al.  Glycosaminoglycans and the regulation of blood coagulation. , 1993, The Biochemical journal.

[13]  A. Donker,et al.  Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus , 1992, The Lancet.

[14]  D. Giugliano,et al.  Protein C Deficiency in Insulin-Dependent Diabetes: A Hyperglycemia-Related Phenomenon , 1990, Thrombosis and Haemostasis.

[15]  T. Sato,et al.  Elevation of Plasma Thrombomodulin Level in Diabetic Patients With Early Diabetic Nephropathy , 1990, Diabetes.

[16]  J. Griffin,et al.  Determination of functional and antigenic protein C inhibitor and its complexes with activated protein C in plasma by ELISA's. , 1989, Thrombosis research.

[17]  S. Yamamoto,et al.  A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation. , 1989, The Journal of biological chemistry.

[18]  C. Esmon.  The regulation of natural anticoagulant pathways , 1987, Science.

[19]  D. Giugliano,et al.  Induced Hyperglycemia Alters Antithrombin III Activity but not its Plasma Concentration in Healthy Normal Subjects , 1987, Diabetes.

[20]  K. Kurachi,et al.  Characterization of a cDNA for human protein C inhibitor. A new member of the plasma serine protease inhibitor superfamily. , 1987, The Journal of biological chemistry.

[21]  J. Griffin,et al.  Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor. , 1986, Blood.

[22]  G. Schernthaner,et al.  Decreased Protein C Levels in Patients With Insulin-Dependent Type I Diabetes Mellitus , 1986, Diabetes.

[23]  L. Wilhelmsen,et al.  Fibrinogen as a risk factor for stroke and myocardial infarction. , 1984, The New England journal of medicine.

[24]  D. Rowe,et al.  Protein creatinine index and Albustix in assessment of proteinuria. , 1983, British medical journal.

[25]  A. Shaw,et al.  Protein creatinine index and Albustix in assessment of proteinuria. , 1983, British medical journal.

[26]  C. Peterson,et al.  The Fluid Phase of Coagulation and the Accelerated Atherosclerosis of Diabetes Mellitus , 1981, Diabetes.

[27]  J. Miletich,et al.  The synthesis of sulfated dextran beads for isolation of human plasma coagulation factors II, IX, and X. , 1980, Analytical biochemistry.

[28]  Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance , 1979, Diabetes.

[29]  H. Keen,et al.  Haemostatic variables associated with diabetes and its complications. , 1979, British medical journal.

[30]  P. Dunn,et al.  A rapid method for the determination of glycosylated hemoglobins using high pressure liquid chromatography. , 1978, Metabolism: clinical and experimental.

[31]  H. Husdan,et al.  Estimation of creatinine by the Jaffe reaction. A comparison of three methods. , 1968, Clinical chemistry.

[32]  M. Samama,et al.  The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions. , 1993, Survey of ophthalmology.

[33]  F. Gonano,et al.  Increased prothrombin fragment 1 + 2 in type I diabetic patients. , 1992, Haemostasis.

[34]  Kevin McConway,et al.  Distribution-free methods , 1987 .

[35]  J. Nishioka,et al.  Monoclonal Antibodies to Human Protein C: Effects on the Biological Activity of Activated Protein C and the Thrombin-Catalyzed Activation of Protein C , 1985 .